<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>LA021589-0039</title>
	</head>
	<body>
		<main>
			<p><P> February 15, 1989, Wednesday, San Diego County Edition  </P> <P> SAN DIEGO EARNINGS  </P> <P> Molecular Biosystems reported a third-quarter profit of $1.2 million on revenue  of $3 million, compared with a profit of $961,578 on revenue of $2.1 million  over the same period last year.  </P> <P> For the nine months ended Dec. 31, the company's profit was $1.6 million on  revenue of $6.1 million, up from a profit of $1.4 million on revenue of $4.3  million over the same three quarters the previous year.  </P> <P> Molecular Biosystems generates minimal revenue from product sales. However, the  company has signed multimillion-dollar marketing and research agreements with  Nycomed of Norway and Mallinckrodt of St. Louis covering Albunex, an ultrasound  imaging product under development.  </P> <P> The company's profit and revenue flow mainly from licensing and research funds  paid by the two companies.  </P></p>
		</main>
</body></html>
            